Biological Effects of LEO 43204 in Actinic Keratosis

Clinical trial NCT02600598 · COMPLETED

Trial details

NCT number: NCT02600598
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2016-07-01
Primary completion: 2016-12-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.